首页> 外文期刊>Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society >Propensity Score-Based Survival Benefit of Simultaneous Liver-Kidney Transplant Over Liver Transplant Alone for Recipients With Pretransplant Renal Dysfunction
【24h】

Propensity Score-Based Survival Benefit of Simultaneous Liver-Kidney Transplant Over Liver Transplant Alone for Recipients With Pretransplant Renal Dysfunction

机译:肝肾合并同时移植患者的基于倾向评分的生存获益优于移植前肾功能不全的患者

获取原文
获取原文并翻译 | 示例
       

摘要

The survival benefit of simultaneous liver-kidney transplantation (SLKT) over liver transplantation alone (LTA) is unclear from the current literature. Additionally, the role of donor kidney quality, measured by the kidney donor risk index (KDRI), in survival benefit of SLKT is not studied. We compared survival benefit after SLKT and LTA among recipients with similar pre-transplant renal dysfunction using novel methodology, specifically with respect to survival probability and area under the survival curve by dialysis status and KDRI. Data were obtained from the Scientific Registry of Transplant Recipients. The study cohort included patients with pre-liver transplantation (LT) renal dysfunction who were wait-listed and received either a SLKT (n=1326) or a LTA (n=4283) between March 1, 2002 and December 31, 2009. Inverse Probability of Treatment Weighting-SLKT and LTA survival curves, along with the 5-year area under the survival curve, were computed by dialysis status at transplant. The difference in the area under the curve represents the average additional survival time gained via SLKT over LTA. For patients not on dialysis, SLKT resulted in a significant 3.7-month gain in 5-year mean posttransplant survival time. The decrease in mortality rate differs significantly by KDRI, and an estimated 76% of SLKT recipients received a kidney with KDRI sufficiently low for mortality. The mortality decrease for SLKT was concentrated in the first year after transplant. The difference between SLKT and LTA 5-year mean posttransplant survival time was 1.4 months and was nonsignificant for patients on dialysis. In conclusion, the propensity score-adjusted survival among SLKT and LTA recipients was similar for those who were on dialysis at LT. Although statistically significant, the survival advantage of SLKT over LTA was of marginal clinical significance among patients not on dialysis and occurred only if the donor kidney was of sufficient quality. These results should be considered in the ongoing debate regarding the allocation of kidneys to extra-renal transplant candidates. (C) 2015 AASLD.
机译:从目前的文献中尚不清楚同时进行肝肾移植(SLKT)优于单纯肝移植(LTA)的生存获益。此外,未研究通过肾脏供体风险指数(KDRI)衡量的供体肾脏质量在SLKT生存获益中的作用。我们使用新方法比较了具有相似移植前肾功能障碍的接受者在SLKT和LTA后的生存获益,特别是关于透析状态和KDRI的生存概率和生存曲线下面积。数据从移植收件人科学注册处获得。该研究队列包括等待入组并在2002年3月1日至2009年12月31日期间接受SLKT(n = 1326)或LTA(n = 4283)的肝移植前(LT)肾功能不全的患者。通过移植时的透析状态计算治疗权重-SLKT和LTA生存曲线的概率,以及生存曲线下的5年面积。曲线下面积的差异表示通过SLKT获得的相对于LTA的平均额外生存时间。对于未接受透析的患者,SLKT可使移植后5年平均生存时间显着增加3.7个月。死亡率的下降因KDRI而有显着差异,估计有76%的SLKT接受者接受的肾脏肾脏病KDRI足够低。 SLKT的死亡率降低主要集中在移植后的第一年。 SLKT和LTA的5年平均移植后生存时间之间的差异为1.4个月,对于透析患者而言无统计学意义。总之,SLKT和LTA接受者的倾向评分调整生存率与LT透析者相似。尽管具有统计学意义,但SLKT优于LTA的生存优势在未接受透析的患者中仅具有边际临床意义,并且仅在供体肾脏质量足够时才会出现。在正在进行的有关将肾脏分配给肾外移植候选者的辩论中应考虑这些结果。 (C)2015 AASLD。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号